|
業務類別
|
-- |
|
業務概覽
|
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve quality of life in patients suffering from debilitating and sometimes deadly diseases. Its products have been approved in the U.S., rheumatoid arthritis, and inflammatory conditions of the gastrointestinal tract such as Crohn's Disease and Ulcerative Colitis as well as various retina disorders characterized by a breakdown of the blood-retinal barrier such as diabetic retinopathy, Aged related macular degeneration and retinal vein occlusion among others. Its pipeline includes its compound EOM613, an investigational novel dynamically dual-acting immunomodulator. |
| 公司地址
| 136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645 |
| 電話號碼
| +1 201 351-0605 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.eompharma.com |
| 員工數量
| 4 |
| Mr. Gary S. Titus |
Chairman of the Board and Secretary |
-- |
14/03/2018 |
|
|
| Dr. Rahul Singhvi |
Independent Director |
14/03/2018 |
| Mr. Gary S. Titus |
Chairman of the Board and Secretary |
14/03/2018 |
| Dr. John S. Yu,M.D. |
Director |
14/03/2018 |
|
|
|
|
